PMDA — authorised 26 March 2019
- Marketing authorisation holder: ZERIA PHARMACEUTICAL CO., LTD.
- Status: approved
🇯🇵 Injectafer in Japan
PMDA authorised Injectafer on 26 March 2019
Marketing authorisation
Injectafer in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Japan
Frequently asked questions
Is Injectafer approved in Japan?
Yes. PMDA authorised it on 26 March 2019.
Who is the marketing authorisation holder for Injectafer in Japan?
ZERIA PHARMACEUTICAL CO., LTD. holds the Japanese marketing authorisation.